newsfilter
← Latest News
Business Wire·

Edwards Lifesciences Reports Second Quarter Results

EW

Edwards Lifesciences (NYSE:EW) today reported financial results for the quarter ended June 30, 2025. Recent Highlights Q2 sales grew 11.9% to $1.53 billion, or 10.6% adjusted1, with strength across all product